BEST BUY CO INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BEST BUY CO INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	39,403	42,151	42,879	43,638	47,262	51,761	46,298	43,452	41,528	41,691
Cost of revenue	29,963	32,275	32,918	33,590	36,689	40,121	36,386	33,849	32,143	32,318
Gross profit	9,440	9,876	9,961	10,048	10,573	11,640	9,912	9,603	9,385	9,373
Selling, general and administrative	7,547	8,023	8,015	7,998	7,928	8,635	7,970	7,876	7,651	7,623
Operating income	1,854	1,843	1,900	2,009	2,391	3,039	1,795	1,574	1,262	1,389
Interest expense	72	75	73	64	52	25	35	52	51	47
Pre-tax income	1,816	1,817	1,888	1,993	2,377	3,024	1,788	1,621	1,295	1,404
Income tax	609	818	424	452	579	574	370	381	372	337
Income from continuing operations	1,207	999	1,464	1,541
Net income	1,228	1,000	1,464	1,541	1,798	2,454	1,419	1,241	927	1,069
EBITDA	2,508	2,526	2,670	2,821	3,230	3,908	2,713	2,497	2,128	2,220
EPS, basic	3.86	3.33	5.30	5.82	6.93	9.94	6.31	5.70	4.31	5.06
EPS, diluted	3.81	3.26	5.20	5.75	6.84	9.84	6.29	5.68	4.28	5.04
Shares, basic (weighted)	319	300	276	265	260	247	225	218	215	211
Shares, diluted (weighted)	323	307	281	268	263	249	226	219	217	212
Dividend per share	1.57	1.36	1.80	2.00	2.20	2.80	3.52	3.68	3.76	3.80

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	2,240	1,101	1,980	2,229	5,494	2,936	1,874	1,447	1,578	1,738
Short-term investments	1,681	2,032	0
Receivables	1,347	1,049	1,015	1,149	1,061	1,042	1,141	939	1,044	1,043
Inventory	4,864	5,209	5,409	5,174	5,612	5,965	5,140	4,958	5,085	5,230
Other current assets	384	438	466	305	373	596	647	553	517	493
Total current assets	10,516	9,829	8,870	8,857	12,540	10,539	8,802	7,897	8,224	8,504
Property, plant and equipment	2,293	2,421	2,510	2,328	2,260	2,250	2,352	2,260	2,122	1,986
Lease right-of-use assets				2,709	2,612	2,654	2,746	2,758	2,833	2,869
Goodwill	425	425	915	984	986	1,384	1,383	1,383	908	790
Intangible assets		18
Other non-current assets	622	374	606	713	669	677	520	669	695	521
Total assets	13,856	13,049	12,901	15,591	19,067	17,504	15,803	14,967	14,782	14,670
Accounts payable	4,984	4,873	5,257	5,288	6,979	6,803	5,687	4,637	4,980	4,745
Accrued liabilities	865	1,001	982	906	972	946	843	902	741	742
Deferred revenue	418	453	290	281
Short-term debt	44	544	56	14	14	13	16	13	10	11
Total current liabilities	7,122	7,817	7,513	8,060	10,521	10,674	8,979	7,909	8,016	7,679
Long-term debt	1,321	811	1,332	1,257	1,253	1,216	1,160	1,152	1,144	1,165
Lease liabilities				2,138	2,012	2,061	2,164	2,199	2,282	2,334
Other non-current liabilities	704	809	750	657	694	533	705	654	532	528
Total liabilities	9,147	9,437	9,595	12,112	14,480	14,484	13,008	11,914	11,974	11,706
Total debt	1,163	544	1,388	1,271	1,267	1,229	1,176	1,165	1,154	1,176
Paid-in capital	0	0	0				21	31	0	14
Retained earnings	4,399	3,270	2,985	3,158	4,233	2,668	2,430	2,683	2,486	2,610
Other comprehensive income	279	314	294	295	328	329	322	317	300	318
Shareholders' equity	4,709	3,612	3,306	3,479	4,587	3,020	2,795	3,053	2,808	2,964
Total equity	4,709	3,612	3,306	3,479	4,587	3,020	2,795	3,053	2,808	2,964
Total liabilities and equity	13,856	13,049	12,901	15,591	19,067	17,504	15,803	14,967	14,782	14,670
Shares outstanding	311	283	266	256	257	227	218	215	211	209

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	1,228	1,000	1,464	1,541	1,798	2,454	1,419	1,241	927	1,069
Depreciation and amortization	654	683	770	812	839	869	918	923	866	831
Stock-based compensation	108	129	123	143	135	141	138	145	139	139
Deferred income tax	201	162	10	70	-36	14	51	-214	-59	60
Change in receivables	-193	315	28	-131	73	17	-103	204	-111	-3
Change in inventory	199	-335	-194	237	-435	-328	809	178	-155	-126
Change in payables	518	-196	432	47	1,676	-201	-1,099	-1,025	358	-238
Cash from operations	2,557	2,141	2,408	2,565	4,927	3,252	1,824	1,470	2,098	1,962
Capital expenditures	-580	-688	-819	-743	-713	-737	-930	-795	-706	-704
Acquisitions	0	0	-787	-145		-468
Purchases of investments	-3,045	-4,325	0	-330	-620	-233	-46	-9	-26	-1
Sales and maturities of investments	2,689	4,018	2,098	322	546	66	7	7	20	0
Cash from investing	-877	-1,002	508	-895	-788	-1,372	-962	-781	-704	-730
Debt issued	0	0	498		1,892
Debt repaid	-394	-46	-546	-15	-1,916	-133	-19	-19	-17	-13
Stock issued	171	163	38	48	28	29	16	19	17	5
Share buybacks	-698	-2,004	-1,505	-1,003	-312	-3,502	-1,014	-340	-500	-273
Dividends paid	-505	-409	-497	-527	-568	-688	-789	-801	-807	-801
Cash from financing	-1,418	-2,297	-2,018	-1,498	-876	-4,297	-1,806	-1,144	-1,309	-1,083
Exchange rate effect	10	25	-14	-1	7	-3	-8	-5	-10
Net change in cash	272	-1,133	884	171	3,270	-2,420	-952	-460	75	155
Free cash flow	1,977	1,453	1,589	1,822	4,214	2,515	894	675	1,392	1,258
Interest paid	76	81	71	62	50	22	31	51	46	44
Income taxes paid	628	366	391	514	442	716	283	543	643	284

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $90.51 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	22.7%	Gross profit / revenue.
Operating margin	4.1%	Operating income / revenue.
EBITDA margin	5.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.1%	Pre-tax income / revenue.
Net margin	3.0%	Net income / revenue.
FCF margin	4.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.9%	Cash from operations / revenue.
Effective tax rate	26.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	40.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.9%	Net income / average total assets.
Return on invested capital (ROIC)	59.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	18.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	1.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-2.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-0.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	10.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-8.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-10.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	4.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-6.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-7.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	15.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-9.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-9.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	17.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-7.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-5.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-6.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	2.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-16.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-9.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	12.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-21.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	1.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.6%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	11.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	5.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-8.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-2.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-5.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.12x	Current assets / current liabilities.
Quick ratio	0.36x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.25x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.37x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	7.3%	Total debt / total assets.
Liabilities / assets	80.2%	Total liabilities / total assets.
Net debt	-$1.09B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.43x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	38.0x	Operating income / interest expense.
Working capital	$1.05B	Current assets - current liabilities.
Goodwill and intangibles / assets	4.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.39B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.62x	Revenue / average total assets.
Fixed asset turnover	21.2x	Revenue / average property, plant and equipment.
Inventory turnover	5.18x	Cost of revenue / average inventory.
Days inventory	70 days	365 x average inventory / cost of revenue.
Receivables turnover	45.8x	Revenue / average receivables.
Days sales outstanding	8 days	365 x average receivables / revenue.
Days payables	67 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	11 days	Days inventory + days sales outstanding - days payables.
FCF conversion	139.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	28.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.98	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$198.41	Revenue / diluted weighted shares.
FCF per share	$8.31	Free cash flow / diluted weighted shares.
Operating cash flow per share	$11.64	Cash from operations / diluted weighted shares.
Book value per share	$15.13	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$11.37	Tangible book value / shares outstanding.
Cash per share	$10.72	(Cash + short-term investments) / shares outstanding.
Payout ratio	63.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	45.4%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	8.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$19.08B	Share price x shares outstanding.
Enterprise value	$17.99B	Market cap + total debt - cash - short-term investments.
P/E	15.0x	Market cap / net income. Only when net income is positive.
P/S	0.45x	Market cap / revenue.
P/B	5.99x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	7.97x	Market cap / tangible book value, when positive.
P/FCF	10.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.71x	Market cap / cash from operations, when positive.
EV/Sales	0.43x	Enterprise value / revenue.
EV/EBIT	10.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.17x	Enterprise value / EBITDA, when both are positive.
EV/FCF	10.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.3%	Free cash flow / market cap.
Earnings yield	6.7%	Net income / market cap (the inverse of P/E).
Dividend yield	4.2%	Dividends paid over the period / market cap.
Shareholder yield	5.0%	(Dividends paid + share buybacks) / market cap.

What was BEST BUY CO INC's revenue in fiscal 2026?

BEST BUY CO INC reported revenue of $41.69B for fiscal 2026, 0.4% higher than the year before.

Was BEST BUY CO INC profitable in fiscal 2026?

Yes. Net income was $1.07B, a net margin of 2.6%.

How much free cash flow did BEST BUY CO INC generate in fiscal 2026?

Cash from operations of $1.96B minus capital expenditures of $704.0M left free cash flow of $1.26B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BEST BUY CO INC